Cost-effectiveness analysis of cinacalcet vs. paricalcitol in the treatment of hyperparathyroidism secondary to chronic kidney disease

INTRODUCTION: For the reduction of PTH levels, two classes of drugs are available in the Brazilian market: non-selective and selective vitamin D receptor activators and calcimimetics. Among the mentioned drugs, the SUS provides oral calcitriol, paricalcitol and cinacalcet. OBJECTIVES: Develop cost-e...

Descripción completa

Detalles Bibliográficos
Autores principales: Ponce, Daniela, Cardoso, Marilia Mastrocolla de Almeida, Rúgolo, Juliana Rodrigues Machado, Molina, Silvana Andrea, de Andrade, Luis Gustavo Modelli, Curado, Daniel da Silva Pereira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Nefrologia 2023
Materias:
Perspectives/Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697162/
https://www.ncbi.nlm.nih.gov/pubmed/37015047
http://dx.doi.org/10.1590/2175-8239-JBN-2022-0126en

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697162/
https://www.ncbi.nlm.nih.gov/pubmed/37015047
http://dx.doi.org/10.1590/2175-8239-JBN-2022-0126en

Ejemplares similares